These are the sources and citations used to research 6BBL0363 Briefing Article. This bibliography was generated on Cite This For Me on

  • Journal

    Chen, J., Wang, J., Shao, J., Gao, Y., Xu, J., Yu, S., Liu, Z. and Jia, L.

    The Unique Pharmacological Characteristics of Mifepristone (RU486): From Terminating Pregnancy to Preventing Cancer Metastasis

    2014 - Medicinal Research Reviews

    In-text: (Chen et al., 2014)

    Your Bibliography: Chen, J., Wang, J., Shao, J., Gao, Y., Xu, J., Yu, S., Liu, Z. and Jia, L., 2014. The Unique Pharmacological Characteristics of Mifepristone (RU486): From Terminating Pregnancy to Preventing Cancer Metastasis. Medicinal Research Reviews, 34(5), pp.979-1000.

  • Journal

    Goyeneche, A. A. and Telleria, C. M.

    Antiprogestins in gynecological diseases

    2014 - Reproduction

    In-text: (Goyeneche and Telleria, 2014)

    Your Bibliography: Goyeneche, A. and Telleria, C., 2014. Antiprogestins in gynecological diseases. Reproduction, 149(1), pp.R15-R33.

  • Journal

    Rocereto, T. F., Brady, W. E., Shahin, M. S., Hoffman, J. S., Small, L., Rotmensch, J. and Mannel, R. S.

    A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study

    2010 - Gynecologic Oncology

    In-text: (Rocereto et al., 2010)

    Your Bibliography: Rocereto, T., Brady, W., Shahin, M., Hoffman, J., Small, L., Rotmensch, J. and Mannel, R., 2010. A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study. Gynecologic Oncology, 116(3), pp.332-334.

  • Journal

    Rocereto, T. F., Saul, H. M., Aikins, J. A. and Paulson, J.

    Phase II Study of Mifepristone (RU486) in Refractory Ovarian Cancer

    2000 - Gynecologic Oncology

    In-text: (Rocereto, Saul, Aikins and Paulson, 2000)

    Your Bibliography: Rocereto, T., Saul, H., Aikins, J. and Paulson, J., 2000. Phase II Study of Mifepristone (RU486) in Refractory Ovarian Cancer. Gynecologic Oncology, 77(3), pp.429-432.

  • Journal

    Rose, F. and Barnea, E.

    Response of human ovarian carcinoma cell lines to antiprogestin mifepristone.

    1996 - Oncogene

    In-text: (Rose and Barnea, 1996)

    Your Bibliography: Rose, F. and Barnea, E., 1996. Response of human ovarian carcinoma cell lines to antiprogestin mifepristone. Oncogene, 12(5), pp.999-1003.

Click here to start building your own bibliography
Keep on Citing!
Cite This For Me:
The Easiest Tool to Create your Bibliographies Online
Join Us!

Save Time and Improve Your Marks with Cite This For Me

10,587 students joined last month!

  • ✔ Save your bibliographies for longer
  • ✔ Quick and accurate citation program
  • ✔ Save time when referencing
  • ✔ Make your student life easy and fun
  • ✔ Pay only once with our Forever plan
  • ✔ Use plagiarism checker
  • ✔ Create and edit multiple bibliographies
Join